Accuracy of SNPs to Predict Risk of HLA Alleles Associated with Drug-Induced Hypersensitivity Events Across Racial Groups

References

• Ernst FR , GrizzleAJ . Drug-related morbidity and mortality: updating the cost-of-illness model . J. Am. Pharm. Assoc. (Wash.)41 ( 2 ), 192 – 199 ( 2001 ).
   PubMedGoogle Scholar
• Shepherd G , MohornP , YacoubK , MayDW . Adverse drug reaction deaths reported in United States vital statistics, 1999–2006 . Ann. Pharmacother.46 ( 2 ), 169 – 175 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pichler WJ . Delayed drug hypersensitivity reactions . Ann. Intern. Med.139 ( 8 ), 683 – 693 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Pichler W , YawalkarN , SchmidS , HelblingA . Pathogenesis of drug-induced exanthems . Allergy57 ( 10 ), 884 – 893 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Bharadwaj M , IllingP , TheodossisA , PurcellAw , RossjohnJ , MccluskeyJ . Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex . Annu. Rev. Pharmacol. Toxicol.52 , 401 – 431 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kaniwa N , SaitoY . Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury . J. Hum. Genet.58 ( 6 ), 317 – 326 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chen P , LinJI , LuCSet al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan . N. Engl. J. Med.364 ( 12 ), 1126 – 1133 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Locharernkul C , LoplumlertJ , LimotaiCet al. Carbamazepine and phenytoin induced Stevens–Johnson syndrome is associated with HLA-B*1502 allele in Thai population . Epilepsia49 ( 12 ), 2087 – 2091 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Ferrell PB Jr , McleodHl . Carbamazepine, HLA-B*1502 and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis. US FDA recommendations . Pharmacogenomics9 ( 10 ), 1543 – 1546 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Mccormack M , AlfirevicA , BourgeoisSet al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans . N. Engl. J. Med.364 ( 12 ), 1134 – 1143 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ozeki T , MushirodaT , YowangAet al. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population . Hum. Mol. Genet.20 ( 5 ), 1034 – 1041 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Martin AM , NolanD , GaudieriSet al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant . Proc. Natl Acad. Sci. USA101 ( 12 ), 4180 – 4185 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Hung SI , ChungWH , LiouLBet al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol . Proc. Natl Acad. Sci. USA102 ( 11 ), 4134 – 4139 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Genin E , SchumacherM , RoujeauJCet al. Genome-wide association study of Stevens–Johnson syndrome and toxic epidermal necrolysis in Europe . Orphanet. J. Rare Dis.6 , 52 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Singer JB , LewitzkyS , LeroyEet al. A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury . Nat. Genet.42 ( 8 ), 711 – 714 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Colombo S , RauchA , RotgerMet al. The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir . J. Infect. Dis.198 ( 6 ), 864 – 867 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Bontadini A . HLA techniques: typing and antibody detection in the laboratory of immunogenetics . Methods56 ( 4 ), 471 – 476 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Chessman D , KostenkoL , LethborgTet al. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity . Immunity28 ( 6 ), 822 – 832 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• De Bakker PI , McveanG , SabetiPCet al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC . Nat. Genet.38 ( 10 ), 1166 – 1172 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Bray RA , HurleyCK , KamaniNRet al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants . Biol. Blood Marrow Transplant.14 ( 9 Suppl. ), 45 – 53 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Sanchez-Giron F , Villegas-TorresB , Jaramillo-VillafuerteKet al. Association of the genetic marker for abacavir hypersensitivity HLA-B*5701 with HCP5 rs2395029 in Mexican Mestizos . Pharmacogenomics12 ( 6 ), 809 – 814 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Badulli C , SestiniR , SbarsiIet al. Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population . Pharmacogenomics13 ( 3 ), 247 – 249 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Melis R , LewisT , MillsonAet al. Copy number variation and incomplete linkage disequilibrium interfere with the HCP5 genotyping assay for abacavir hypersensitivity . Genet. Test. Mol. Biomarkers16 ( 9 ), 1111 – 1114 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Daly AK . Human leukocyte antigen (HLA) pharmacogenomic tests: potential and pitfalls . Curr. Drug Metab.15 ( 2 ), 196 – 201 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Tassaneeyakul W , JantararoungtongT , ChenPet al. Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population . Pharmacogenet. Genomics19 ( 9 ), 704 – 709 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Kaniwa N , SaitoY , AiharaMet al. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis . Pharmacogenomics9 ( 11 ), 1617 – 1622 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Mallal S , PhillipsE , CarosiGet al. HLA-B*5701 screening for hypersensitivity to abacavir . N. Engl. J. Med.358 ( 6 ), 568 – 579 ( 2008 ).
   PubMed Web of Science ®Google Scholar